Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Snyder Douglas B., Directeur Juridique. Director active across 2 companies, notably GW Pharmaceuticals PLC. Cumulatively, 2 reports have been recorded. History available since 30 May 2025. The latest transaction was filed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Douglas B. Snyder serves as Chief Legal Officer at GW Pharmaceuticals PLC. He oversees the legal affairs of the company, ensuring regulatory compliance and protecting the company's interests. His expertise in business law is essential for the success of the organization.